Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up. - Du XL; Simpson LM; Osani MC; Yama JM; Davis BR (Journal of Alzheimer's disease & Parkinsonism, 2022)